Sevelamer Hydrochloride&Carbonate

Welcome to Dwaey, specifically on Sevelamer Hydrochloride&Carbonate page.
This medicine contains important and useful components, as it consists of
Sevelamer Hydrochloride&Carbonate is available in the market in concentration.

Generic Name of Sevelamer Hydrochloride&Carbonate - Learn More

Sevelamer Hydrochloride&Carbonate

Sevelamer Hydrochloride&Carbonate Precaution - What You Need to Know

Before using Sevelamer Hydrochloride or Sevelamer Carbonate, patients should consult with their healthcare provider due to several important precautions:
- Gastrointestinal issues: Sevelamer can cause gastrointestinal discomfort, including nausea, vomiting, constipation, and diarrhea. These side effects are common and may resolve over time; however, persistent or severe symptoms should be addressed with a healthcare provider.
- Electrolyte imbalances: Sevelamer may affect the balance of electrolytes, particularly calcium, phosphate, and bicarbonate. Regular monitoring of electrolyte levels is advised to avoid complications like hypercalcemia or hypocalcemia.
- Risk in patients with swallowing difficulties: Since Sevelamer tablets should be swallowed whole, patients with swallowing difficulties should be cautious. A liquid formulation is available for some individuals, but this should be confirmed with the prescribing physician.
- Kidney function monitoring: Sevelamer is primarily used in patients with chronic kidney disease (CKD) undergoing hemodialysis. Kidney function should be carefully monitored, as the drug's efficacy is linked to dialysis treatment.
- Pregnancy and breastfeeding: Sevelamer should be used during pregnancy only if the potential benefits outweigh the risks. Limited data exist regarding its use during pregnancy, so it should only be prescribed after careful consideration. Sevelamer is not expected to pass into breast milk significantly, but it should be used with caution during breastfeeding.
- Allergic reactions: Though rare, some individuals may develop an allergic reaction to Sevelamer, presenting with symptoms such as rash, itching, or swelling. Immediate medical attention should be sought if these symptoms appear.

Sevelamer Hydrochloride&Carbonate Indication - Uses and Benefits

Sevelamer Hydrochloride and Sevelamer Carbonate are primarily indicated for the management of:
- Hyperphosphatemia in chronic kidney disease (CKD): Sevelamer is prescribed for the reduction of elevated serum phosphate levels in patients with CKD, particularly those undergoing dialysis. Elevated phosphate levels in these patients can lead to complications like bone disease, cardiovascular issues, and calcification of soft tissues.
- Dialysis patients: Both formulations are primarily used in patients undergoing hemodialysis or peritoneal dialysis to control phosphate levels and prevent complications associated with phosphate retention. This is important in preventing mineral and bone disorders that can arise from phosphate buildup.
- Hyperphosphatemia management in patients who cannot use calcium-based phosphate binders: Sevelamer provides an alternative to calcium-based binders in patients who may be at risk of developing hypercalcemia from calcium supplementation.

Sevelamer is used as part of a comprehensive approach to treating CKD, alongside dietary changes, monitoring of phosphate intake, and other phosphate-lowering treatments.

Sevelamer Hydrochloride&Carbonate Contraindications - Important Warnings

Sevelamer Hydrochloride and Sevelamer Carbonate are contraindicated in certain conditions:
- Bowel obstruction: Patients with a history or risk of bowel obstruction should avoid using Sevelamer, as the drug may worsen the condition. The medication can cause gastrointestinal issues, and patients with pre-existing bowel problems may experience more severe side effects.
- Hypophosphatemia: Sevelamer should not be used in patients with low phosphate levels (hypophosphatemia), as it may exacerbate the deficiency and lead to complications.
- Severe gastrointestinal disorders: Patients with severe gastrointestinal disorders, such as Crohn's disease or ulcerative colitis, should not take Sevelamer unless specifically prescribed by a healthcare provider. The drug may cause further irritation or exacerbation of these conditions.
- Known hypersensitivity to Sevelamer: Sevelamer should not be used in patients who have a known allergy or hypersensitivity to the drug or any of its components.

Sevelamer Hydrochloride&Carbonate Side Effects - What to Expect

Common side effects of Sevelamer Hydrochloride and Sevelamer Carbonate include:
- Gastrointestinal disturbances: These are the most commonly reported side effects and include nausea, vomiting, diarrhea, constipation, abdominal pain, and indigestion.
- Flatulence (gas): Some patients may experience increased flatulence while taking Sevelamer.
- Headache: Headaches can occur in some patients, though this is less common.
- Hypocalcemia (low calcium levels): In some cases, Sevelamer may cause low calcium levels, leading to symptoms like muscle cramps, dizziness, and numbness.
- Fatigue and weakness: These can also occur, though they are less frequent.
- Severe side effects:
- Bowel obstruction: Rarely, Sevelamer can cause bowel obstruction or perforation, particularly in patients with underlying gastrointestinal issues.
- Severe allergic reactions: These are rare but can include symptoms such as rash, itching, swelling, and difficulty breathing.

Patients experiencing severe gastrointestinal issues, signs of a bowel obstruction, or allergic reactions should seek immediate medical attention.

Sevelamer Hydrochloride&Carbonate Pregnancy Category ID - Safety Information

3

Sevelamer Hydrochloride&Carbonate Mode of Action - How It Works

Sevelamer Hydrochloride and Sevelamer Carbonate are phosphate binders. Their primary mechanism of action involves binding to dietary phosphate in the gastrointestinal tract. This binding prevents the absorption of phosphate into the bloodstream. As a result, phosphate levels in the body decrease, which is particularly important in patients with chronic kidney disease (CKD) undergoing dialysis. In CKD, the kidneys are unable to effectively filter excess phosphate, leading to dangerous buildup in the blood, which can cause bone disease, cardiovascular problems, and soft tissue calcification.

By binding phosphate and preventing its absorption, Sevelamer helps to maintain phosphate balance, preventing these complications. Sevelamer also does not contain calcium, unlike some other phosphate binders, making it suitable for patients who need to avoid calcium buildup.

Sevelamer Hydrochloride&Carbonate Drug Interactions - What to Avoid

Sevelamer Hydrochloride and Sevelamer Carbonate can interact with various medications, potentially affecting their absorption and efficacy:
- Levothyroxine: Sevelamer may reduce the absorption of levothyroxine, a common thyroid medication. Therefore, if both drugs are prescribed, levothyroxine should be taken at least 4 hours before Sevelamer.
- Ciprofloxacin: Sevelamer may interfere with the absorption of ciprofloxacin, an antibiotic. It is recommended that ciprofloxacin be taken 2 hours before or 6 hours after Sevelamer.
- Other oral medications: Since Sevelamer binds to dietary phosphate and other substances in the gastrointestinal tract, it may reduce the absorption of other oral medications, including vitamins, minerals, and certain drugs. It is advised to space out the administration of other medications by at least 1 hour before or 3 hours after taking Sevelamer.
- Calcium-containing supplements: If a patient is also taking calcium supplements for bone health or hyperparathyroidism, careful monitoring is required to avoid calcium overloading.
- Iron supplements: Sevelamer can decrease the absorption of oral iron, which is often used in dialysis patients to manage anemia. An alternative iron supplementation strategy or administration timing may be necessary.

Patients should inform their healthcare provider of all other medications they are taking to avoid potential interactions.

Sevelamer Hydrochloride&Carbonate Adult Dose - Recommended Dosage

The typical adult dosage for Sevelamer Hydrochloride or Sevelamer Carbonate depends on the patient's phosphate levels, dietary intake, and dialysis regimen:
- Initial dose: The starting dose is usually 800–1600 mg of Sevelamer per meal. The exact dose is determined based on the severity of hyperphosphatemia and patient response.
- Maintenance dose: Once the patient's phosphate levels are controlled, the dose may be adjusted to a maintenance dose of 800–1600 mg per meal.
- Maximum dose: In some cases, the dose can be increased up to 4800 mg per day, divided across meals, to achieve the desired effect on phosphate levels.

The medication is taken with meals, as it works by binding to the phosphate in the food consumed.

Sevelamer Hydrochloride&Carbonate Child Dose - Dosage for Children

Sevelamer is not typically recommended for use in children unless prescribed by a healthcare provider for specific conditions, such as chronic kidney disease or hyperphosphatemia. The use of Sevelamer in pediatric patients, especially those under 18, should be based on clinical judgment and careful monitoring of phosphate levels. Dosing for children is typically adjusted based on weight and clinical response, and should follow the guidance of a pediatric nephrologist.

Given the specialized use of Sevelamer in children, it is essential that pediatric dosing be determined on a case-by-case basis.

Sevelamer Hydrochloride&Carbonate Renal Dose - Dosage for Kidney Conditions

Sevelamer Hydrochloride and Sevelamer Carbonate are primarily used in patients with chronic kidney disease (CKD), particularly those undergoing dialysis. Since these patients have reduced renal clearance, dosing adjustments may be necessary, especially in those with a reduced glomerular filtration rate (GFR). However, Sevelamer is not significantly cleared by the kidneys, so no specific dose adjustment is required for patients with mild to moderate renal impairment.

For patients with severe renal impairment (stage 5 CKD or those on dialysis), the standard dose is used, but close monitoring of phosphate levels is required to adjust dosing as needed.